Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement. 2024;20:5143–69. https://doi.org/10.1002/alz.13859.

Article  PubMed  PubMed Central  Google Scholar 

Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et al. Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12:292–323. https://doi.org/10.1016/j.jalz.2016.02.002.

Article  PubMed  PubMed Central  Google Scholar 

Jia J, Ning Y, Chen M, Wang S, Yang H, Li F, et al. Biomarker changes during 20 years preceding Alzheimer’s disease. N Engl J Med. 2024;390:712–22. https://doi.org/10.1056/NEJMoa2310168.

Article  PubMed  CAS  Google Scholar 

van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388:9–21. https://doi.org/10.1056/NEJMoa2212948.

Article  PubMed  Google Scholar 

Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512–27. https://doi.org/10.1001/jama.2023.13239.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804. https://doi.org/10.1056/NEJMoa1202753.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yau W-Y, Tudorascu DL, McDade EM, Ikonomovic S, James JA, Minhas D, et al. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer’s disease: a prospective cohort study. Lancet Neurol. 2015;14:804–13. https://doi.org/10.1016/s1474-4422(15)00135-0.

Article  PubMed  PubMed Central  Google Scholar 

McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. 2018;91:e1295–306. https://doi.org/10.1212/wnl.0000000000006277.

Article  PubMed  PubMed Central  Google Scholar 

Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer’s disease: a longitudinal study. Lancet Neurol. 2018;17:241–50. https://doi.org/10.1016/s1474-4422(18)30028-0.

Article  PubMed  PubMed Central  Google Scholar 

Pettigrew C, Soldan A, Wang J, Wang M-C, Greenberg B, Albert M, et al. Longitudinal CSF Alzheimer’s disease biomarker changes from middle age to late adulthood. Alzheimers Dement Diagn Assess Dis Monit. 2022;14:e12374-e. https://doi.org/10.1002/dad2.12374.

Article  Google Scholar 

Schaap T, Thropp P, Tosun D. Timing of Alzheimer’s disease biomarker progressions: a two-decade observational study from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2024;20:9060–7. https://doi.org/10.1002/alz.14306.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hadjichrysanthou C, Evans S, Bajaj S, Siakallis LC, McRae-McKee K, de Wolf F, et al. The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease. Alzheimers Res Ther. 2020;12:74. https://doi.org/10.1186/s13195-020-00636-z.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jack CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease. Brain. 2009;132:1355–65. https://doi.org/10.1093/brain/awp062.

Article  PubMed  PubMed Central  Google Scholar 

Oxtoby NP, Young AL, Cash DM, Benzinger TLS, Fagan AM, Morris JC, et al. Data-driven models of dominantly-inherited Alzheimer’s disease progression. Brain. 2018;141:1529–44. https://doi.org/10.1093/brain/awy050.

Article  PubMed  PubMed Central  Google Scholar 

Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, et al. A data-driven model of biomarker changes in sporadic Alzheimer’s disease. Brain. 2014;137:2564–77. https://doi.org/10.1093/brain/awu176.

Article  PubMed  PubMed Central  Google Scholar 

Koval I, Bone A, Louis M, Lartigue T, Bottani S, Marcoux A, et al. AD course map charts Alzheimer’s disease progression. Sci Rep. 2021;11:8020. https://doi.org/10.1038/s41598-021-87434-1.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Young AL, Oxtoby NP, Garbarino S, Fox NC, Barkhof F, Schott JM, et al. Data-driven modelling of neurodegenerative disease progression: thinking outside the black box. Nat Rev Neurosci. 2024;25:111–30. https://doi.org/10.1038/s41583-023-00779-6.

Article  PubMed  CAS  Google Scholar 

Marinescu RV, Eshaghi A, Lorenzi M, Young AL, Oxtoby NP, Garbarino S, et al. DIVE: a spatiotemporal progression model of brain pathology in neurodegenerative disorders. Neuroimage. 2019;192:166–77. https://doi.org/10.1016/j.neuroimage.2019.02.053.

Article  PubMed  Google Scholar 

Vogel JW, Young AL, Oxtoby NP, Smith R, Ossenkoppele R, Strandberg OT, et al. Four distinct trajectories of tau deposition identified in Alzheimer’s disease. Nat Med. 2021;27:871–81. https://doi.org/10.1038/s41591-021-01309-6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sivera R, Delingette H, Lorenzi M, Pennec X, Ayache N. A model of brain morphological changes related to aging and Alzheimer’s disease from cross-sectional assessments. Neuroimage. 2019;198:255–70. https://doi.org/10.1016/j.neuroimage.2019.05.040.

Article  PubMed  Google Scholar 

Nader CA, Ayache N, Robert P. Monotonic Gaussian process for spatio-temporal disease progression modeling in brain imaging data. Neuroimage. 2020;205:116266. https://doi.org/10.1016/j.neuroimage.2019.116266.

Article  Google Scholar 

Bossa MN, Sahli H. A multidimensional ODE-based model of Alzheimer’s disease progression. Sci Rep. 2023;13:3162. https://doi.org/10.1038/s41598-023-29383-5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bilgel M, Prince JL, Wong DF, Resnick SM, Jedynak BM. A multivariate nonlinear mixed effects model for longitudinal image analysis: application to amyloid imaging. Neuroimage. 2016;134:658–70. https://doi.org/10.1016/j.neuroimage.2016.04.001.

Article  PubMed  PubMed Central  Google Scholar 

Whittington A, Sharp DJ, Gunn RN. Spatiotemporal distribution of β-Amyloid in Alzheimer disease is the result of heterogeneous regional carrying capacities. Alzheimers Dis N. 2018;59:822–7. https://doi.org/10.2967/jnumed.117.194720.

Article  CAS  Google Scholar 

Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference. Nat Commun. 2018;9:4273. https://doi.org/10.1038/s41467-018-05892-0.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schindler SE, Li Y, Buckles VD, Gordon BA, Benzinger TLS, Wang G, et al. Predicting symptom onset in sporadic Alzheimer disease with amyloid PET. Neurology. 2021;97:e1823–34. https://doi.org/10.1212/wnl.0000000000012775.

Article  PubMed  PubMed Central  Google Scholar 

Bilgel M, Jedynak BM. Predicting time to dementia using a quantitative template of disease progression. Alzheimers Dement (Amst). 2019;11:205–15. https://doi.org/10.1016/j.dadm.2019.01.005.

Article  PubMed  PubMed Central  Google Scholar